Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
Is This Battered Growth Stock Still a Buy After Its Latest Stumble?
08:30am, Thursday, 11'th Aug 2022
Its flagship vaccine product isn't selling as much as it used to.
3 Companies Growing Revenue Fast
02:23pm, Wednesday, 10'th Aug 2022
S&P 500 stocks have posted average growth of 6.54% in annual total revenue from 2017 to 2021. The benchmark index for the U.S. stock market closed at 4,122.47 on Tuesday, up nearly 70% over the past f
Novavax (NVAX) Q2 Earnings Miss, Cuts '22 Sales Guidance by Half
01:32pm, Tuesday, 09'th Aug 2022
Novavax (NVAX) reports dismal results in second-quarter 2022. The stock dives in after-market trading after management slashes revenue guidance for 2022 by half.
Novavax tumbles 31% as waning COVID-19 vaccine demand hits revenue forecast
11:45am, Tuesday, 09'th Aug 2022
Novavax fell 31% Tuesday amid falling demand for the COVID-19 shot from low and middle-income nations, which caused the company to cut its annual expectations in half.
Novavax CEO on COVID-19 boosters: ‘I dont think we're too late'
11:30am, Tuesday, 09'th Aug 2022
Novavax CEO Stanley Erck speaks with Yahoo Finance's Anjalee Khemlani about the company's cut forecast for vaccine sales, its outlook for COVID booster development, and growth.
Novavax cuts 2022 revenue guidance in half, plus Good RX soars resolves issue with grocery chain
11:20am, Tuesday, 09'th Aug 2022
Yahoo Finance's Anjalee Khemlani breaks down quarterly earnings for Novavax and GoodRx as well as how the market is reacting.
Stock Market Today: Dow Jones, S&P 500 Drop Ahead Of Key Inflation Data; Novavax Stock Falls After Cutting Revenue Guidance
11:00am, Tuesday, 09'th Aug 2022
Stock market indices fell Tuesday morning ahead of key inflation data.
Novavax tumbles 31% as waning COVID vaccine demand hits revenue forecast
07:36am, Tuesday, 09'th Aug 2022
U.S. vaccine maker Novavax slumped nearly 31% on Tuesday as falling demand for its COVID-19 shot from low- and middle-income nations led the company to cut its annual revenue expectation by half.
Novavax slumps after halving its sales forecast amid global supply glut and low vaccine demand
04:57am, Tuesday, 09'th Aug 2022
Shares in Novavax, Inc. (NASDAQ:NVAX) tanked 33.64% in after-hours trading after the company halved its full-year revenue forecast due to a global supply glut and weak demand for its Covid-19 vaccin
Novavax Stock Slides 29% on Steep Cut to Sales Forecast
04:29am, Tuesday, 09'th Aug 2022
The Covid-19 vaccine maker says it expects revenue this year of $2 billion to $2.3 billion, down from previous expectations of $4 billion to $5 billion.
Novavax, Inc.'s (NVAX) CEO Stan Erck on Q2 2022 Results - Earnings Call Transcript
09:28pm, Monday, 08'th Aug 2022
Novavax, Inc. (NASDAQ:NVAX ) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Silvia Taylor – Senior Vice President-Global Corporate Affairs and Investor Relations Sta
Novavax (NVAX) Reports Q2 Loss, Misses Revenue Estimates
07:34pm, Monday, 08'th Aug 2022
Novavax (NVAX) delivered earnings and revenue surprises of -218.51% and 82.16%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Novavax Stock Got Mashed on Monday
06:26pm, Monday, 08'th Aug 2022
Investors sold out of the company after it fell short with second-quarter results.
Novavax shares just tanked 35%: find out why
05:58pm, Monday, 08'th Aug 2022
Shares of Novavax Inc (NASDAQ: NVAX) tanked nearly 35% in extended trading on Monday after the biotech company reported thoroughly disappointing results for its fiscal second quarter and lowered its a
Novavax Plummets: Covid Vaccine Sales Widely Lag On Unexpected Losses, Slashed Guidance
05:30pm, Monday, 08'th Aug 2022
Novavax widely missed second-quarter forecasts Tuesday, leading the Covid vaccine maker to slash its guidance and NVAX stock to crash. The post Novavax Plummets: Covid Vaccine Sales Widely Lag On Unex
